메뉴 건너뛰기




Volumn 332, Issue 1, 2005, Pages 304-310

Characterization of the cloned full-length and a truncated human target of rapamycin: Activity, specificity, and enzyme inhibition as studied by a high capacity assay

Author keywords

Anticancer; High throughput screening; Kinase inhibitor; PIKK; Rapamycin; TOR

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; RAPAMYCIN; WORTMANNIN;

EID: 19344375090     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.117     Document Type: Article
Times cited : (35)

References (17)
  • 1
    • 0034644525 scopus 로고    scopus 로고
    • TOR, a central controller of cell growth
    • T. Schmelzle, and M.N. Hall TOR, a central controller of cell growth Cell 103 2000 253 562
    • (2000) Cell , vol.103 , pp. 253-562
    • Schmelzle, T.1    Hall, M.N.2
  • 2
    • 2342545519 scopus 로고    scopus 로고
    • Target of rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
    • D.C. Fingar, and J. Blenis Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression Oncogene 23 2004 3151 3171
    • (2004) Oncogene , vol.23 , pp. 3151-3171
    • Fingar, D.C.1    Blenis, J.2
  • 3
    • 0028800996 scopus 로고
    • PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints
    • C.T. Keith, and S.L. Schreiber PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints Science 270 1995 50 51
    • (1995) Science , vol.270 , pp. 50-51
    • Keith, C.T.1    Schreiber, S.L.2
  • 6
    • 0029831167 scopus 로고    scopus 로고
    • Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002
    • G.J. Brunn, J. Williams, C. Sabers, G. Wiederrecht, J.C. Lawrence Jr., and R.T. Abraham Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002 EMBO J. 15 1996 5256 5267
    • (1996) EMBO J. , vol.15 , pp. 5256-5267
    • Brunn, G.J.1    Williams, J.2    Sabers, C.3    Wiederrecht, G.4    Lawrence Jr., J.C.5    Abraham, R.T.6
  • 7
    • 2342559981 scopus 로고    scopus 로고
    • The TOR pathway: A target for cancer therapy
    • M.A. Bjornsti, and P.J. Houghton The TOR pathway: a target for cancer therapy Nat. Rev. Cancer 4 2004 335 348
    • (2004) Nat. Rev. Cancer , vol.4 , pp. 335-348
    • Bjornsti, M.A.1    Houghton, P.J.2
  • 8
    • 11244297916 scopus 로고    scopus 로고
    • Dysregulation of the TSC-mTOR pathway in human disease
    • K. Inoki, M.N. Corradetti, and K.L. Guan Dysregulation of the TSC-mTOR pathway in human disease Nat. Genet. 37 2005 19 24
    • (2005) Nat. Genet. , vol.37 , pp. 19-24
    • Inoki, K.1    Corradetti, M.N.2    Guan, K.L.3
  • 9
    • 4444245893 scopus 로고    scopus 로고
    • Determination of the catalytic activities of mTOR and other members of the phosphoinositide-3-kinase-related kinase family
    • G.G. Chiang, and R.T. Abraham Determination of the catalytic activities of mTOR and other members of the phosphoinositide-3-kinase-related kinase family Methods Mol. Biol. 28 2004 125 141
    • (2004) Methods Mol. Biol. , vol.28 , pp. 125-141
    • Chiang, G.G.1    Abraham, R.T.2
  • 11
    • 0033548071 scopus 로고    scopus 로고
    • The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin- associated protein kinase activity and G1 progression
    • M. Vilella-Bach, P. Nuzzi, Y. Fang, and J. Chen The FKBP12-rapamycin- binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression J. Biol. Chem. 274 1999 4266 4272
    • (1999) J. Biol. Chem. , vol.274 , pp. 4266-4272
    • Vilella-Bach, M.1    Nuzzi, P.2    Fang, Y.3    Chen, J.4
  • 12
    • 0029842109 scopus 로고    scopus 로고
    • Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP
    • J. Choi, J. Chen, S.L. Schreiber, and J. Clardy Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP Science 273 1996 239 242
    • (1996) Science , vol.273 , pp. 239-242
    • Choi, J.1    Chen, J.2    Schreiber, S.L.3    Clardy, J.4
  • 14
    • 0033551234 scopus 로고    scopus 로고
    • Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein
    • R.T. Peterson, B.N. Desai, J.S. Hardwick, and S.L. Schreiber Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein Proc. Natl. Acad. Sci. USA 96 1999 4438 4442
    • (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 4438-4442
    • Peterson, R.T.1    Desai, B.N.2    Hardwick, J.S.3    Schreiber, S.L.4
  • 15
    • 0034629365 scopus 로고    scopus 로고
    • FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions
    • R.T. Peterson, P.A. Beal, M.J. Comb, and S.L. Schreiber FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions J. Biol. Chem. 275 2000 7416 7423
    • (2000) J. Biol. Chem. , vol.275 , pp. 7416-7423
    • Peterson, R.T.1    Beal, P.A.2    Comb, M.J.3    Schreiber, S.L.4
  • 16
    • 0033634827 scopus 로고    scopus 로고
    • Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine
    • E.H. Walker, M.E. Pacold, O. Perisic, L. Stephens, P.T. Hawkins, M.P. Wymann, and R.L. Williams Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine Mol. Cell 6 2000 909 919
    • (2000) Mol. Cell , vol.6 , pp. 909-919
    • Walker, E.H.1    Pacold, M.E.2    Perisic, O.3    Stephens, L.4    Hawkins, P.T.5    Wymann, M.P.6    Williams, R.L.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.